- Home
- BRTX vs SANW Comparison
BRTX vs SANW Comparison
Compare BRTX & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- SANW
- Stock Information
- Founded
- BRTX 1997
- SANW 1980
- Country
- BRTX United States
- SANW United States
- Employees
- BRTX N/A
- SANW N/A
- Industry
- BRTX Managed Health Care
- SANW Farming/Seeds/Milling
- Sector
- BRTX Health Care
- SANW Consumer Staples
- Exchange
- BRTX Nasdaq
- SANW Nasdaq
- Market Cap
- BRTX 15.9M
- SANW 18.8M
- IPO Year
- BRTX N/A
- SANW 2010
- Fundamental
- Price
- BRTX $1.80
- SANW $7.50
- Analyst Decision
- BRTX Strong Buy
- SANW Strong Buy
- Analyst Count
- BRTX 1
- SANW 1
- Target Price
- BRTX $18.00
- SANW $35.00
- AVG Volume (30 Days)
- BRTX 812.7K
- SANW 8.3K
- Earning Date
- BRTX 03-28-2025
- SANW 02-13-2025
- Dividend Yield
- BRTX N/A
- SANW N/A
- EPS Growth
- BRTX N/A
- SANW N/A
- EPS
- BRTX N/A
- SANW N/A
- Revenue
- BRTX $377,000.00
- SANW $54,809,365.00
- Revenue This Year
- BRTX $482.76
- SANW N/A
- Revenue Next Year
- BRTX $212.24
- SANW $9.92
- P/E Ratio
- BRTX N/A
- SANW N/A
- Revenue Growth
- BRTX 189.55
- SANW N/A
- 52 Week Low
- BRTX $1.03
- SANW $2.10
- 52 Week High
- BRTX $2.55
- SANW $13.49
- Technical
- Relative Strength Index (RSI)
- BRTX 37.55
- SANW 37.23
- Support Level
- BRTX $2.26
- SANW $7.10
- Resistance Level
- BRTX $2.38
- SANW $8.10
- Average True Range (ATR)
- BRTX 0.22
- SANW 0.65
- MACD
- BRTX -0.09
- SANW -0.25
- Stochastic Oscillator
- BRTX 7.98
- SANW 15.33
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.